Healthcare provider profile · identity verified

Christopher Yusko, D.O.

Internal Medicine · MOUNT POCONO, PA · NPI 1649223405

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	979	287
Amlodipine Besylate	Amlodipine Besylate	458	147
Lisinopril	Lisinopril	343	103
Levothyroxine Sodium	Levothyroxine Sodium	327	87
Losartan Potassium	Losartan Potassium	282	89
Metformin Hcl	Metformin Hcl	282	77
Omeprazole	Omeprazole	262	82
Gabapentin	Gabapentin	256	76
Rosuvastatin Calcium	Rosuvastatin Calcium	226	83
Metoprolol Succinate	Metoprolol Succinate	200	62
Pantoprazole Sodium	Pantoprazole Sodium	196	58
Albuterol Sulfate Hfa	Albuterol Sulfate	176	73
Fluticasone Propionate	Fluticasone Propionate	173	68
Sertraline Hcl	Sertraline Hcl	163	52
Ozempic	Semaglutide	158	30
Tamsulosin Hcl	Tamsulosin Hcl	158	43
Hydrochlorothiazide	Hydrochlorothiazide	141	51
Furosemide	Furosemide	132	41
Famotidine	Famotidine	122	40
Jardiance	Empagliflozin	112	30
Trazodone Hcl	Trazodone Hcl	106	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	27
Mirtazapine	Mirtazapine	101	27
Montelukast Sodium	Montelukast Sodium	97	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	94	26
Escitalopram Oxalate	Escitalopram Oxalate	93	31
Carvedilol	Carvedilol	92	28
Spironolactone	Spironolactone	88	21
Tizanidine Hcl	Tizanidine Hcl	87	28
Clopidogrel	Clopidogrel Bisulfate	86	24
Prednisone	Prednisone	86	62
Bupropion Xl	Bupropion Hcl	85	31
Buspirone Hcl	Buspirone Hcl	84	21
Metoprolol Tartrate	Metoprolol Tartrate	84	26
Tramadol Hcl	Tramadol Hcl	84	31
Citalopram Hbr	Citalopram Hydrobromide	83	18
Hydroxyzine Hcl	Hydroxyzine Hcl	82	27
Pregabalin	Pregabalin	82	20
Glimepiride	Glimepiride	81	22
Duloxetine Hcl	Duloxetine Hcl	79	24
Eliquis	Apixaban	79	27
Diclofenac Sodium	Diclofenac Sodium	76	28
Meloxicam	Meloxicam	76	22
Oxybutynin Chloride Er	Oxybutynin Chloride	76	18
Metformin Hcl Er	Metformin Hcl	69	28
Mounjaro	Tirzepatide	69	suppressed
Warfarin Sodium	Warfarin Sodium	69	18
Ropinirole Hcl	Ropinirole Hcl	66	17
Alendronate Sodium	Alendronate Sodium	64	22
Baclofen	Baclofen	63	29
Venlafaxine Hcl Er	Venlafaxine Hcl	58	15
Azithromycin	Azithromycin	56	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	22
Zolpidem Tartrate	Zolpidem Tartrate	56	14
Allopurinol	Allopurinol	54	16
Alprazolam	Alprazolam	54	suppressed
Atenolol	Atenolol	53	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	14
Clonazepam	Clonazepam	49	12
Simvastatin	Simvastatin	47	13
Ondansetron Hcl	Ondansetron Hcl	44	14
Valsartan	Valsartan	38	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	31
Methocarbamol	Methocarbamol	35	18
Trulicity	Dulaglutide	35	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	12
Potassium Chloride	Potassium Chloride	33	11
Benazepril Hcl	Benazepril Hcl	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	24
Ibuprofen	Ibuprofen	30	12
Lorazepam	Lorazepam	30	11
Nifedipine Er	Nifedipine	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Torsemide	Torsemide	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Naproxen	Naproxen	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	17
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	25	16
Celecoxib	Celecoxib	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Mometasone Furoate	Mometasone Furoate	24	suppressed
Ketoconazole	Ketoconazole	23	11
Klor-Con M20	Potassium Chloride	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Glipizide	Glipizide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Finasteride	Finasteride	15	suppressed
Metolazone	Metolazone	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Colchicine	Colchicine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Topiramate	Topiramate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Unifine Pentips	Pen Needle, Diabetic	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Estradiol	Estradiol	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Risperidone	Risperidone	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error